Global Insomnia Therapeutics Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 112
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Insomnia Therapeutics Drugs market size was valued at USD 3006.2 million in 2023 and is forecast to a readjusted size of USD 3764 million by 2030 with a CAGR of 3.3% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Insomnia Therapeutics Drugs industry chain, the market status of Prescription (Benzodiazepines, Nonbenzodiazepines), Over-the-Counter (OTC) (Benzodiazepines, Nonbenzodiazepines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Insomnia Therapeutics Drugs.
Regionally, the report analyzes the Insomnia Therapeutics Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Insomnia Therapeutics Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Insomnia Therapeutics Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Insomnia Therapeutics Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Benzodiazepines, Nonbenzodiazepines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Insomnia Therapeutics Drugs market.
Regional Analysis: The report involves examining the Insomnia Therapeutics Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Insomnia Therapeutics Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Insomnia Therapeutics Drugs:
Company Analysis: Report covers individual Insomnia Therapeutics Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Insomnia Therapeutics Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prescription, Over-the-Counter (OTC)).
Technology Analysis: Report covers specific technologies relevant to Insomnia Therapeutics Drugs. It assesses the current state, advancements, and potential future developments in Insomnia Therapeutics Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Insomnia Therapeutics Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Market segment by Application
Prescription
Over-the-Counter (OTC)
Market segment by players, this report covers
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Insomnia Therapeutics Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Insomnia Therapeutics Drugs, with revenue, gross margin and global market share of Insomnia Therapeutics Drugs from 2019 to 2024.
Chapter 3, the Insomnia Therapeutics Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Insomnia Therapeutics Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Insomnia Therapeutics Drugs.
Chapter 13, to describe Insomnia Therapeutics Drugs research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Insomnia Therapeutics Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Insomnia Therapeutics Drugs by Type
1.3.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Insomnia Therapeutics Drugs Consumption Value Market Share by Type in 2023
1.3.3 Benzodiazepines
1.3.4 Nonbenzodiazepines
1.3.5 Antidepressants
1.3.6 Orexin Antagonists
1.3.7 Melatonin Antagonists
1.3.8 Others
1.4 Global Insomnia Therapeutics Drugs Market by Application
1.4.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prescription
1.4.3 Over-the-Counter (OTC)
1.5 Global Insomnia Therapeutics Drugs Market Size & Forecast
1.6 Global Insomnia Therapeutics Drugs Market Size and Forecast by Region
1.6.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Insomnia Therapeutics Drugs Market Size by Region, (2019-2030)
1.6.3 North America Insomnia Therapeutics Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Insomnia Therapeutics Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Insomnia Therapeutics Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Insomnia Therapeutics Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Insomnia Therapeutics Drugs Market Size and Prospect (2019-2030)
2.1 Takeda Pharmaceutical Company Ltd.
2.1.1 Takeda Pharmaceutical Company Ltd. Details
2.1.2 Takeda Pharmaceutical Company Ltd. Major Business
2.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
2.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.2 Vanda Pharmaceuticals
2.2.1 Vanda Pharmaceuticals Details
2.2.2 Vanda Pharmaceuticals Major Business
2.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
2.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Vanda Pharmaceuticals Recent Developments and Future Plans
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
2.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck & Co., Inc. Recent Developments and Future Plans
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
2.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Inc. Recent Developments and Future Plans
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
2.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.6 Mylan N.V.
2.6.1 Mylan N.V. Details
2.6.2 Mylan N.V. Major Business
2.6.3 Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
2.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mylan N.V. Recent Developments and Future Plans
2.7 Sumitomo Dainippon Pharma Co., Ltd
2.7.1 Sumitomo Dainippon Pharma Co., Ltd Details
2.7.2 Sumitomo Dainippon Pharma Co., Ltd Major Business
2.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
2.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Insomnia Therapeutics Drugs Product and Solutions
2.8.4 Sanofi Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Paratek Pharmaceuticals Inc.
2.9.1 Paratek Pharmaceuticals Inc. Details
2.9.2 Paratek Pharmaceuticals Inc. Major Business
2.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
2.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Paratek Pharmaceuticals Inc. Recent Developments and Future Plans
2.10 Ebb Therapeutics
2.10.1 Ebb Therapeutics Details
2.10.2 Ebb Therapeutics Major Business
2.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
2.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ebb Therapeutics Recent Developments and Future Plans
3.1 Global Insomnia Therapeutics Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Insomnia Therapeutics Drugs by Company Revenue
3.2.2 Top 3 Insomnia Therapeutics Drugs Players Market Share in 2023
3.2.3 Top 6 Insomnia Therapeutics Drugs Players Market Share in 2023
3.3 Insomnia Therapeutics Drugs Market: Overall Company Footprint Analysis
3.3.1 Insomnia Therapeutics Drugs Market: Region Footprint
3.3.2 Insomnia Therapeutics Drugs Market: Company Product Type Footprint
3.3.3 Insomnia Therapeutics Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Insomnia Therapeutics Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Insomnia Therapeutics Drugs Market Forecast by Type (2025-2030)
5.1 Global Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Insomnia Therapeutics Drugs Market Forecast by Application (2025-2030)
6.1 North America Insomnia Therapeutics Drugs Consumption Value by Type (2019-2030)
6.2 North America Insomnia Therapeutics Drugs Consumption Value by Application (2019-2030)
6.3 North America Insomnia Therapeutics Drugs Market Size by Country
6.3.1 North America Insomnia Therapeutics Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
7.1 Europe Insomnia Therapeutics Drugs Consumption Value by Type (2019-2030)
7.2 Europe Insomnia Therapeutics Drugs Consumption Value by Application (2019-2030)
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country
7.3.1 Europe Insomnia Therapeutics Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
7.3.3 France Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region
8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Region (2019-2030)
8.3.2 China Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.3.5 India Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
9.1 South America Insomnia Therapeutics Drugs Consumption Value by Type (2019-2030)
9.2 South America Insomnia Therapeutics Drugs Consumption Value by Application (2019-2030)
9.3 South America Insomnia Therapeutics Drugs Market Size by Country
9.3.1 South America Insomnia Therapeutics Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country
10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Insomnia Therapeutics Drugs Market Size and Forecast (2019-2030)
11.1 Insomnia Therapeutics Drugs Market Drivers
11.2 Insomnia Therapeutics Drugs Market Restraints
11.3 Insomnia Therapeutics Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Insomnia Therapeutics Drugs Industry Chain
12.2 Insomnia Therapeutics Drugs Upstream Analysis
12.3 Insomnia Therapeutics Drugs Midstream Analysis
12.4 Insomnia Therapeutics Drugs Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Insomnia Therapeutics Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Insomnia Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Insomnia Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Takeda Pharmaceutical Company Ltd. Company Information, Head Office, and Major Competitors
Table 6. Takeda Pharmaceutical Company Ltd. Major Business
Table 7. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 8. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Table 10. Vanda Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Vanda Pharmaceuticals Major Business
Table 12. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
Table 13. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Vanda Pharmaceuticals Recent Developments and Future Plans
Table 15. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 16. Merck & Co., Inc. Major Business
Table 17. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 18. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Merck & Co., Inc. Recent Developments and Future Plans
Table 20. Pfizer Inc. Company Information, Head Office, and Major Competitors
Table 21. Pfizer Inc. Major Business
Table 22. Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 23. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Inc. Recent Developments and Future Plans
Table 25. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 26. Teva Pharmaceutical Industries Ltd. Major Business
Table 27. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 28. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 30. Mylan N.V. Company Information, Head Office, and Major Competitors
Table 31. Mylan N.V. Major Business
Table 32. Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
Table 33. Mylan N.V. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Mylan N.V. Recent Developments and Future Plans
Table 35. Sumitomo Dainippon Pharma Co., Ltd Company Information, Head Office, and Major Competitors
Table 36. Sumitomo Dainippon Pharma Co., Ltd Major Business
Table 37. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
Table 38. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Insomnia Therapeutics Drugs Product and Solutions
Table 43. Sanofi Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. Paratek Pharmaceuticals Inc. Company Information, Head Office, and Major Competitors
Table 46. Paratek Pharmaceuticals Inc. Major Business
Table 47. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 48. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Paratek Pharmaceuticals Inc. Recent Developments and Future Plans
Table 50. Ebb Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Ebb Therapeutics Major Business
Table 52. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
Table 53. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Ebb Therapeutics Recent Developments and Future Plans
Table 55. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Insomnia Therapeutics Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Insomnia Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Insomnia Therapeutics Drugs Players
Table 60. Insomnia Therapeutics Drugs Market: Company Product Type Footprint
Table 61. Insomnia Therapeutics Drugs Market: Company Product Application Footprint
Table 62. Insomnia Therapeutics Drugs New Market Entrants and Barriers to Market Entry
Table 63. Insomnia Therapeutics Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Insomnia Therapeutics Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Insomnia Therapeutics Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Insomnia Therapeutics Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024)
Table 68. Global Insomnia Therapeutics Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Insomnia Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Insomnia Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Insomnia Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Insomnia Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Insomnia Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Insomnia Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Insomnia Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Insomnia Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Insomnia Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Insomnia Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Insomnia Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Insomnia Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Insomnia Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Insomnia Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Insomnia Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Insomnia Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Insomnia Therapeutics Drugs Raw Material
Table 100. Key Suppliers of Insomnia Therapeutics Drugs Raw Materials
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Insomnia Therapeutics Drugs Consumption Value Market Share by Type in 2023
Figure 4. Benzodiazepines
Figure 5. Nonbenzodiazepines
Figure 6. Antidepressants
Figure 7. Orexin Antagonists
Figure 8. Melatonin Antagonists
Figure 9. Others
Figure 10. Global Insomnia Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Insomnia Therapeutics Drugs Consumption Value Market Share by Application in 2023
Figure 12. Prescription Picture
Figure 13. Over-the-Counter (OTC) Picture
Figure 14. Global Insomnia Therapeutics Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Insomnia Therapeutics Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Insomnia Therapeutics Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Insomnia Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Insomnia Therapeutics Drugs Consumption Value Market Share by Region in 2023
Figure 19. North America Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Insomnia Therapeutics Drugs Revenue Share by Players in 2023
Figure 25. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Insomnia Therapeutics Drugs Market Share in 2023
Figure 27. Global Top 6 Players Insomnia Therapeutics Drugs Market Share in 2023
Figure 28. Global Insomnia Therapeutics Drugs Consumption Value Share by Type (2019-2024)
Figure 29. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2025-2030)
Figure 30. Global Insomnia Therapeutics Drugs Consumption Value Share by Application (2019-2024)
Figure 31. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2025-2030)
Figure 32. North America Insomnia Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Insomnia Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Insomnia Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Insomnia Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. France Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Insomnia Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 49. China Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. India Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Insomnia Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Insomnia Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Insomnia Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Insomnia Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Insomnia Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Insomnia Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 66. Insomnia Therapeutics Drugs Market Drivers
Figure 67. Insomnia Therapeutics Drugs Market Restraints
Figure 68. Insomnia Therapeutics Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Insomnia Therapeutics Drugs in 2023
Figure 71. Manufacturing Process Analysis of Insomnia Therapeutics Drugs
Figure 72. Insomnia Therapeutics Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda Pharmaceutical Company Ltd. Vanda Pharmaceuticals Merck & Co., Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd. Mylan N.V. Sumitomo Dainippon Pharma Co., Ltd Sanofi Paratek Pharmaceuticals Inc. Ebb Therapeutics
Related Reports
25 Feb 2021
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
